ATORX — Alligator Bioscience AB Share News
0.000.00%
Last trade - 00:00- SEK89.83m
- SEK103.14m
- SEK0.51m
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue
Advisory: Alerts on Alligator Bioscience conducting rights issue withdrawn
Advisory: Alerts on Alligator Bioscience conducting rights issue withdrawn
Sweden's Alligator Bioscience Q2 loss widens, no sales
Brief: Alligator Bioscience Q2 EBIT SEK -36.2 Million
Brief: Alligator Bioscience To Focus On HLX22 Project, Carry Out Rights Issue
Brief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln
Brief: Alligator Bioscience Gets Patent In United States
Sweden's Alligator Bioscience Q4 net loss widens
Brief: Alligator Bioscience Q4 EBIT SEK -22.5 Million
Brief: Alligator Bioscience Resolves On Directed Issue Of 18,585,000 Units
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue